News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
PFREUNDSCHUH PETER P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/05/2023 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Sold 13,567 shares
@ $6.99, valued at
$94.8k
|
|
| 10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/22/2023 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 38,000 shares
@ $0
Granted 76,000 options to buy
@ $7.43, valued at
$564.7k
|
|
| 10/04/2022 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 125,000 shares
@ $0 |
|
| 09/21/2022 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on Voyager Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $6.18, valued at
$1.2M
|
|
| 09/21/2022 |
3
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 3 on Voyager Therapeutics, Inc. |
| 02/23/2022 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on Frequency Therapeutics, Inc.|
Txns:
| Sold 1,404 shares
@ $3.877, valued at
$5.4k
Sold 1,542 shares
@ $3.529, valued at
$5.4k
|
|
| 02/18/2022 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on Frequency Therapeutics, Inc.|
Txns:
| Sold 1,229 shares
@ $4.429, valued at
$5.4k
Sold 1,296 shares
@ $4.2, valued at
$5.4k
Granted 150,000 restricted stock units
@ $0 |
|
| 02/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2021 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on Frequency Therapeutics, Inc.|
Txns:
| Granted 30,000 restricted stock units
@ $0 |
|
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2020 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on Frequency Therapeutics, Inc.|
Txns:
| Granted 230,000 options
@ $27.3, valued at
$6.3M
|
|
| 12/03/2020 |
3
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 3 on Frequency Therapeutics, Inc. |
| 10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/01/2020 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 509 shares
@ $22.82, valued at
$11.6k
Exercised 1,042 restricted stock units
@ $0 |
|
| 07/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2020 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 358 shares
@ $25.07, valued at
$9k
Exercised 1,041 restricted stock units
@ $0 |
|
| 04/28/2020 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 141 shares
@ $24.35, valued at
$3.4k
Exercised 417 restricted stock units
@ $0 |
|
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Granted 15,000 options to buy
@ $29.41, valued at
$441.2k
Granted 6,000 restricted stock units
@ $0 |
|
| 01/28/2020 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 667 shares
@ $29.28, valued at
$19.5k
Exercised 1,666 options to buy
@ $0 |
|
| 11/22/2019 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 354 shares
@ $28.41, valued at
$10.1k
Exercised 1,042 restricted stock units
@ $0 |
|
| 08/22/2019 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on UroGen Pharma Ltd.|
Txns:
| Sold 1,416 shares
@ $33.07, valued at
$46.8k
Exercised 4,167 restricted stock units
@ $0 |
|
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2019 |
3
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 3 on UroGen Pharma Ltd. |
| 02/13/2018 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 263 shares
@ $18, valued at
$4.7k
Disposed/sold 150,000 options to buy
@ $10.9, valued at
$1.6M
|
|
| 01/12/2018 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Granted 131 shares
@ $9.1, valued at
$1.2k
Granted 263 shares
@ $9.1, valued at
$2.4k
|
|
| 03/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/22/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 08/24/2015 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 15,341 shares
@ $0
Granted 38,484 options to buy
@ $1.76, valued at
$67.7k
|
|
| 03/11/2015 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 50,000 options to buy
@ $4.01, valued at
$200.5k
|
|
| 08/18/2014 |
4
| PFREUNDSCHUH PETER P. (CFO) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 15,813 shares
@ $0
Granted 87,895 options to buy
@ $3.32, valued at
$291.8k
|
|
| 09/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|